JNCI Journal of the National Cancer Institute · 1973 · 114 citations · 0 references
MedicineOncologyPharmacologyCancer ImmunologyOncology PharmacotherapyTumor ImmunologyInterferon ResponsesInterferon-based TherapyOncogenic VirusesInterferon Alfa TherapyInterferon Alpha-2b Therapy
Interferon has limited in vivo antitumor activity when host tumor load is great. When systemic leukemia is arrested by drug therapy which leads to a reduction of tumor cells, subsequent treatment with interferon leads to a significant number of cures. The combined drug and interferon treatment exerts a synergistic antitumor effect.